ODM

XClinical, Exhibitor and Speaker at the 44th Annual DIA Meeting in Boston

XClinical executives will showcase the company’s innovations regarding products and services. Dr. Claus Lindenau will hold a lecture in the session “CDISC SDTM Data Conversion”. XClinical GmbH, Munich, Germany – June 17, 2008 – XClinical, a European vendor of innovative software products for e-clinical trials, and known for its innovative CDISC certified EDC software suite MARVIN, today announced its participation at the 44th Annual DIA Meeting to be held on June 22 to 26, 2008, in Boston, MA, USA. “The forthcoming DIA event will welcome attendees from all geographic locations, making it the perfect venue for global networking opportunities”, said Dr. Lindenau, XClinical’s head of business development. After XClinical’s successful expansion into the U.S. market last year, the company’s next step is now to further strengthen its presence in the United States. BioStat International Inc. (BSI), XClinical’s recent U.S. client,...

XClinical’s Key Executives to Present at CDISC in Copenhagen, Further Emphasizing its Activity in the Adoption of Data Standards

XClinical’s CEO, Dr. Philippe Verplancke, has been selected to speak at the CDISC European Interchange in Copenhagen in April 2008 where he will discuss the challenges of combining user-friendliness and CDISC data standards in an EDC system. XClinical is furthermore contributing to the CDISC End-to-End Workshop (“CORE”). Dr. Verplancke has recently been invited to perform the official ODM/define.xml trainings and will be an official guest speaker at CDISC road shows and user-group meetings in 2008. XCLINICAL GMBH, Munich, Germany – April 9, 2008 – XClinical, a European vendor of innovative software products for eClinical trials and well known for MARVIN, one of the first CDISC certified EDC software solutions, today announced its comprehensive participation at the CDISC European Interchange to be held on April 21-25, 2008, at The Marriott Hotel in Copenhagen, Denmark. XClinical’s CEO, Dr. Philippe Verplancke, has been invited to...

Inhalt abgleichen